Content about Antifungals

July 27, 2012
Mylan launches antifungal drug

Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

PITTSBURGH — Mylan has launched a generic drug for treating fungal infections, the drug maker said Friday.

Mylan announced the launch of itraconazole capsules in the 100-mg strength. The drug is a generic version of Johnson & Johnson's Sporanox, which is used to treat fungal infections that begin in the lungs blatsomycosis, histoplasmosis and aspergillosis in patients who are intolerant of or refractory to amphotericin B therapy. The drug also is used to treat fungal infections in the toenails and fingernails in patients without compromised immune systems.

May 31, 2012
Mexican athlete's foot brand making its way across the border to U.S. Hispanic markets

MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

EL SEGUNDO, Calif. — MarcasUSA on Thursday announced the U.S. debut of Conazol, a leading over-the-counter athlete's foot treatment in Mexico.

The brand is expanding its U.S. distribution and can be found at such retailers as Walmart and Target in key U.S. Hispanic markets, such as Los Angeles, Houston, Dallas and Chicago, the company said.

May 23, 2012
FDA approves treatment for vaginal fungus infections

The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic treatment made by Perrigo for fungal infections of the vagina, the company said.

Perrigo announced the approval of butoconazole nitrate 2% vaginal cream, a generic version of KV Pharmaceutical's Gynazole-1, used to treat vulvovaginal candidiasis, an infection caused by Candida fungus. KV voluntarily discontinued selling the drug in January 2009 due to manufacturing problems.

December 19, 2011
FDA approves Sandoz drug for fungal infections

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

PRINCETON, N.J. — The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

Sandoz announced Monday the approval of voriconazole tablets in the 50-mg and 200-mg strengths, a generic version of Pfizer's Vfend.

Branded and generic versions of the drug had sales of about $189 million during the 12-month period ended in October, according to IMS Health.

 

August 30, 2011
FDA approves Perrigo, Cobrek dermatitis drug

The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.

ALLEGAN, Mich. — The Food and Drug Administration has approved a treatment for dermatitis made by Perrigo under a collaboration with Chicago-based Cobrek Pharmaceutical.

The drug maker said Tuesday that the FDA approved ketoconazole foam in the 2% strength. The drug is a generic version of Stiefel Labs' Extina, a topical drug used to treat seborrheic dermatitis in patients ages 12 years and older with healthy immune systems.

Extina has annual sales of about $10 million, according to Perrigo.

August 19, 2011
NexMed gains FDA approval of Tolnaftate-D

NexMed USA on Thursday received clearance from the Food and Drug Administration to market the company's first over-the-counter antifungal drug, Tolnaftate-D.

SAN DIEGO — NexMed USA on Thursday received clearance from the Food and Drug Administration to market the company's first over-the-counter antifungal drug, Tolnaftate-D.

NexMed USA's Tolnaftate-D incorporates NexACT, a proprietary drug delivery technology that transiently loosens the tight junction between the cells of the sealed skin to allow more permeation.

March 21, 2011
Hi-Tech Pharmacal acquires candidiasis treatment

Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.

Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.

The market for the drug is $23 million, according to IMS Health.

February 15, 2011
Mylan gets approval for generic version of Vfend

Mylan has launched a generic drug for fungal infections, the company said Tuesday.

PITTSBURGH — Mylan has launched a generic drug for fungal infections, the company said Tuesday.

Mylan announced the launch, through subsidiary Mylan Pharmaceuticals, of voriconazole tablets in the 50-mg and 200-mg strengths. The drug is a triazole antifungal agent.

The tablets are a generic version of Pfizer’s Vfend, which had sales of $186 million in 2010, according to IMS Health. Mylan launched its version of the drug under a settlement with Pfizer.

June 9, 2010
FDA approves generic Lamisil from Breckenridge

The Food and Drug Administration has approved Breckenridge Pharmaceutical’s generic version of a fungal infection...

June 2, 2010
Perrigo receives FDA approval for generic Monistat-1 Combination Pack

Perrigo on Thursday announced that it has received final approval from the Food and Drug...

January 26, 2010
Head & Shoulders mans up

Procter & Gamble's Head & Shoulders brand is stepping into the men's grooming segment with...

September 19, 2007
Teva introduces generic Penlac

Teva is introducing its generic to the Sanofi-Aventis anti-fungal medication Penlac nail lacquer....